Hydromorphone is a
drug which was researched and developed in Germany in
1924, and introduced to the mass market beginning in 1926. It is used to relieve moderate to severe
pain and severe, painful dry coughing. Hydromorphone is known by the trade names Hydal, Sophidone, Hydrostat, Hydromorfan, Hydromorphan, Laudicon, and most famously, Dilaudid. An extended-release version called Palladone SR was available for a short time in the United States before being voluntarily withdrawn from the market after an FDA advisory released in July 2005 warned of a high overdose potential when taken with alcohol; it is still available in the United Kingdom as of March 2007. Another extended-release version called Hydromorph Contin, manufactured as controlled release capsules, continues to be produced and distributed in Canada by Purdue Pharma Inc. in Pickering, Ontario.
See more at Wikipedia.org...